---
title: "Regencell Bioscience (RGC.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/RGC.US/norm.md"
symbol: "RGC.US"
name: "Regencell Bioscience"
parent: "https://longbridge.com/en/quote/RGC.US.md"
datetime: "2026-05-20T14:39:57.446Z"
locales:
  - [en](https://longbridge.com/en/quote/RGC.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/RGC.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/RGC.US/norm.md)
---

# Regencell Bioscience (RGC.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
| --- | --- | --- | --- | --- | --- |
| EPS | -0.0054 | -0.0054 | -0.0017 | -0.0017 | -0.0019 |
| ROE | -872.24% | -349.89% | -71.21% | -59.80% | -55.21% |
| Revenue | - | - | - | - | - |
| Net income | -2.66M | -2.66M | -865300.00 | -865300.00 | -926806.00 |
| Operating income | -2.67M | -2.67M | -896075.00 | -896075.00 | -988917.00 |
| Gross margin | - | - | - | - | - |
| Net margin | - | - | - | - | - |
| Profit quality | - | - | - | - | - |

## Balance Sheet (USD)

| Indicator | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
| --- | --- | --- | --- | --- | --- |
| A&L | 3.01M | 3.01M | 5.76M | 5.76M | 7.48M |
| Leverage | 2.47 | 2.47 | 1.18 | 1.18 | 1.11 |
| BVPS | 0.0025 | 0.0025 | 0.0098 | 0.0098 | 0.0136 |
| Turnover | - | - | - | - | - |
| Cash & STI | 2.36M | 2.36M | 4.90M | 4.90M | - |
| Inv & Rec | - | - | - | - | - |
| LT assets | 562731.00 | 562731.00 | 759819.00 | 759819.00 | - |
| Net debt | -1.97M | -1.97M | -4.35M | -4.35M | - |

## Cash Flow Statement (USD)

| Indicator | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -1.30M | -1.30M | - | - | -851934.00 |
| Investing CF | 1.25M | 1.25M | - | - | 127777.00 |
| Financing CF | - | - | - | - | - |
| Free CF | -1.67M | -606288.00 | - | - | - |
| OCF coverage | - | - | - | - | - |
| Repaid & issued | - | - | - | - | - |
| CapEx | - | - | - | - | - |